AbbVie (ABBV) Change in Acquisitions & Divestments (2012 - 2025)

AbbVie (ABBV) has 14 years of Change in Acquisitions & Divestments data on file, last reported at $34.0 million in Q4 2025.

• Change in Acquisitions & Divestments for Q4 2025 came in at $34.0 million, down 12.82% year-over-year; the trailing twelve-month figure through Dec 2025 was $76.0 million (down 86.31% YoY), and the FY2025 annual result was $76.0 million, down 86.31% from the prior year.
• Change in Acquisitions & Divestments climbed to $34.0 million in Q4 2025 per ABBV's latest filing, from $3.0 million in the prior quarter.
• Over five years, Change in Acquisitions & Divestments peaked at $1.4 billion in Q3 2022 and troughed at $3.0 million in Q2 2024.
• A 5-year average of $115.7 million and a median of $18.0 million in 2023 frame the typical range for Change in Acquisitions & Divestments.
• The sharpest annual moves came in 2023 and 2024: Change in Acquisitions & Divestments sank 99.65% in 2023, then soared 10040.0% in 2024.
• A 5-year view of Change in Acquisitions & Divestments shows it stood at $10.0 million in 2021, then jumped by 600.0% to $70.0 million in 2022, then slumped by 80.0% to $14.0 million in 2023, then jumped by 178.57% to $39.0 million in 2024, then declined by 12.82% to $34.0 million in 2025.
• Business Quant data shows ABBV's Change in Acquisitions & Divestments at $34.0 million in Q4 2025, $3.0 million in Q3 2025, and $7.0 million in Q2 2025.